| abstract |
Disclosed are a medicament for treating, preventing or delaying progression of dyskinesia associated with dopamine agonist therapy in Parkinson's disease, and a medicament for treating or delaying progression of Parkinson's disease. A dyskinesia comprising (R) -3- (6-p-tolyl-pyridin-3-yloxy) -1-aza-bicyclo [2.2.2] octane in free base form or acid addition salt form , Dopamine agonists, and (R) -3- (6-p-tolyl-pyridin-3-yloxy) -1-aza- in free base form or acid addition salt form A medicament for treating or delaying the progression of Parkinson's disease, comprising bicyclo [2.2.2] octane. The dopamine agonist is preferably levodopa. [Selection figure] None |